Gonçalo Rebelo de Andrade is Chief of Business Operations at Nanoform Finland. Before that he was Director at Hovione Technology. He holds a PhD in Biochemistry from Ludwig Maximillian University in Munich and earned his Lisbon MBA course degree at Nova/Catolica Business School. He joined the Hovione group in 2013 as a business development manager for inhalation drug development services and for the dry powder inhalers within Hovione’s portfolio, which he led until March 2016. Dr Andrade has >15 years’ experience in the life sciences sector in the US, Germany and Portugal where he worked for both large companies and startups and a clear vision on the hurdles connected to the drug development of inhaled drugs.

More contributions